Menu
ncarol.com
  • Home
  • Health
  • Real Estate
  • Business
  • Non-profit
  • Education
  • Beauty
  • Books
  • Services
ncarol.com

Angels for Change 2024 Drug Shortage Guardian Awarded to Fresenius Kabi USA
ncarol.com/10262612

Trending...
  • Lineus Medical Receives Patent for SafeBreak® Vascular Generation 2
  • Guests Can Save 10 Percent Off New Vacation Rental Homes at KeysCaribbean's Village at Hawks Cay Villas
  • Paylode Acquired by Moved to Power the Next Generation of Ancillary Revenue Automation
TAMPA, Fla. - ncarol.com -- Angels for Change, a global non-profit on a mission to end drug shortages, presented the organization's 2024 Drug Shortage Guardian Award to Fresenius Kabi USA, a health care company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition.

Fresenius Kabi USA received the award in recognition of its exceptional teamwork and patient focus during the critical chemotherapy shortages of 2023. The patient-centric focus and culture of Fresenius Kabi enabled the company to rapidly increase output and urgently steward emergency supply to thousands of customers and patients in need of critical therapies.

The Drug Shortage Guardian Award is presented annually to an organization and its people for exhibiting exceptional patient-centered work during a drug shortage crisis. Angels for Change defines a guardian as a "defender; one who guards, protects those in need."

"It is important to recognize individuals within the supply chain for extraordinary, patient-focused work. In highlighting gold-standard work we foster change and support building the resilient supply chain of the future. We are proud to present our 2024 Guardian Award to Fresenius Kabi and its amazing employees who tirelessly strive to ensure patient access to lifesaving medicines across the country, even in dire shortage situations," said Founder and Chief Change Maker of Angels for Change, Laura Bray.

More on ncarol.com
  • ZEELOOL 2025 Black Friday and Cyber Monday Big Deals
  • Americans Are Building Family Legacies That Last Generations — Not Just Paychecks That Last a Month
  • A $7 Ticket Could Rewrite Someone's Destiny — 327 Acres of U.S. Land to Be Won by Anyone, Anywh
  • Bent Danholm Lists Contemporary Lakefront Residence in Winter Garden's Avalon Cove
  • Safe Health Zones: A Global Breakthrough to Protect Night-Shift Workers from Preventable Harm

In addition to recognizing Fresenius Kabi USA, Angels for Change also presented individual Drug Shortage Guardian Awards to two Fresenius employees: Karen Twardzik, Vice President, Customer Service Operations, and Danielle Gross, Manager, Customer Service.

These guardians' extraordinary work and leadership exceeded their normal tasks to navigate within the supply chain to ensure life-saving medicines were delivered to customers and patients experiencing dire shortages. Their heroic efforts helped save lives across the nation.

"At Fresenius Kabi, we exist to put lifesaving medicines and technologies in the hands of people who care for patients. We are honored to receive this recognition from Angels for Change and look forward to supporting the important work of Laura and the mission of Angels for Change. We will continue to do our part to put an end to essential medicine (or drug) shortages," said John Ducker, president and CEO, Fresenius Kabi, Region U.S.

The awards were presented at Fresenius Kabi's U.S. headquarters in Lake Zurich, Ill. on May 16th, 2024. Fresenius Kabi USA leadership and employees joined Angels for Change founder Laura Bray during the award presentation. Following this meeting another presentation occurred at nearby Melrose Park, Ill. where Fresenius Kabi operates a state-of-the art sterile injectable manufacturing site. Here, Bray presented a guardian award to Fresenius Kabi frontline workers who have worked tirelessly to increase supply of needed medicines for patients.

More on ncarol.com
  • ProfileSpider Launches Powerful One-Click Profile Scraper for Recruiters and Growth Teams
  • NATCO Awarded U.S. Patent for Persimonal® – Breakthrough Innovation in Preparing Persimmon Leaf Extract
  • Little Wheels Adds Parent Recording to Vehicle Tales, Turning Bedtime Stories into Family Keepsakes
  • Rio Bela Cosmetics Launches Inclusive Line of Organic Skincare Products
  • The 7 Visibility Problems Costing Independent Hotels Thousands Every Month

About Angels for Change

Angels for Change is a volunteer-supported, global, 501c3 organization started in Tampa, Fla. that is on a mission to end drug shortages through advocacy, awareness, and a resilient supply chain. Founder, Laura Bray, was driven to start Angels for Change after her own child faced three life-saving drug shortages in nine months of pediatric cancer treatment. Each day Angels for Change advocates on behalf of any patient in a life-saving drug shortage, while building relationships with patients and members of the pharmaceutical supply chain to end all healthcare crises created by drug shortages.

www.angelsforchange.org

About Fresenius Kabi USA

Fresenius Kabi, an operating company of Fresenius, is a global healthcare organization that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company's products and services are used for the therapy and care of patients with critical and chronic conditions. The company is actively involved in efforts to end drug shortages, has invested nearly a billion dollars in U.S. pharmaceutical manufacturing and distribution, and is a past recipient of a Drug Shortage Assistance Award from the U.S. Food and Drug Administration. www.fresenius-kabi.com/us/

Contact
communications@angelsforchanges.org


Source: AngelsForChange.org
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Federal Lawsuit Claims Raleigh DA Lorrin Freeman and Police Chief Rico Boyce Concealed Evidence
  • We're Winning: Historic Plunge in Overdose Deaths Marks Stunning Reversal in America's Drug Crisis
  • Lineus Medical Receives Patent for SafeBreak® Vascular Generation 2
  • New 2025–2026 Energy Rebates: Squeaks Services Explains How to Qualify
  • CCHR's New Documentary Prescription for Violence Highlights Overlooked Safety Warnings
  • Men's Health Network Announces a New Feature to Support the Well-Being of Men When and Where They Are through Text Alerts
  • Comp-U-Floor Unveils Powerful New Commercial Module
  • Revenue Optics Announces the Appointment of Sonal Chowdhury as Senior Manager – Strategic Operations
  • How California Convinces Buyers Not to Purchase New Cars — and How This Hurts Dealers
  • Tax Fears and Political Volatility Drive Wealthy UK Residents to Consider Leaving, La Vida Survey Shows
  • Titan Steel Buildings Expands Nationwide to Deliver Large Steel Warehouses and Industrial Facilities
  • Marry Me Marinara Announces New Gourmet Pasta Sauce - Bringing Restaurant Quality to Home Kitchens
  • Kaltra Removes Size Barriers for Microchannel Coils with Fully Integrated Large-MCHE Production
  • Guests Can Save 10 Percent Off New Vacation Rental Homes at KeysCaribbean's Village at Hawks Cay Villas
  • Paylode Acquired by Moved to Power the Next Generation of Ancillary Revenue Automation
  • Global Preschool Giants Unite to Celebrate the 12th Anniversary of Badanamu's Hit Song "Ponytail"
  • America's Leading Annuity Expert Carlton Cap Averil II Joins Tom Hegna on "Financial Freedom with Tom Hegna"
  • Cheeron Partners with CRCC to Support Shanghai East Railway Station
  • MiBoxer Shines at 2025 Hong Kong International Lighting Fair, Intelligent Lighting Solutions Acclaimed by Global Clients
  • Anern Launches the AN-SLZ2 Smart Integrated Solar Street Light
_catLbl0 _catLbl1

Popular on ncarol.com

  • Heritage at South Brunswick's Townhome Models Coming Soon! - 170
  • Arc Longevity Sells Out Debut Women's Creatine Gummy - 168
  • Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Dominate Raleigh's Best Awards from The News & Observer - 163
  • $300 Million Web3 Initiative and ZIGChain Partnership Power $20 Target in Noble Capital Markets Report for SEGG Media (N A S D A Q: SEGG) - 160
  • $430 Million 2026 Revenue Forecast; 26% Organic Growth; $500,000 Stock Dividend Highlight a Powerful AI & Digital Transformation Story: IQSTEL $IQST - 157
  • Parkchester Oral & Maxillofacial Surgery Celebrates 450+ 5-Star Reviews - 120
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • Assent Recognizes Manufacturers for Leading Supply Chain Sustainability Programs
  • Lick Pineapple Flavored Massage Oil Outperforming and Enticing
  • Bookmakers Review Releases 2028 Democratic Nominee Betting Odds: Newsom Leads Early Field

Similar on ncarol.com

  • Safe Health Zones: A Global Breakthrough to Protect Night-Shift Workers from Preventable Harm
  • NATCO Awarded U.S. Patent for Persimonal® – Breakthrough Innovation in Preparing Persimmon Leaf Extract
  • Althea Gibson Honored as Final Release in U.S. Mint's American Women Quarters Program
  • Dr. Alexander Eastman Returns to Suburban Hospital to Deliver Keynote on Crisis Leadership
  • Monika Balayan Elected Fellow of the Royal Society of Arts (FRSA)
  • We're Winning: Historic Plunge in Overdose Deaths Marks Stunning Reversal in America's Drug Crisis
  • Lineus Medical Receives Patent for SafeBreak® Vascular Generation 2
  • CCHR's New Documentary Prescription for Violence Highlights Overlooked Safety Warnings
  • Men's Health Network Announces a New Feature to Support the Well-Being of Men When and Where They Are through Text Alerts
  • Sustainable Santa Returns to Old Sacramento
Copyright © 2025 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute